<DOC>
	<DOCNO>NCT00266149</DOCNO>
	<brief_summary>The present study evaluate effect oral contraceptive lamotrigine plasma concentration double blind , placebo control , cross-over study patient epilepsy .</brief_summary>
	<brief_title>Lamotrigine Oral Contraceptives</brief_title>
	<detailed_description>Lamotrigine widely use antiepileptic drug treatment newly onset well refractory epilepsy ( 1 ; 2 ) . Lamotrigine unique among antiepileptic drug since major route ( 76 % ) elimination conjugation glucuronic acid ( glucuronidation ) ( 3 ) . This conjugation reaction catalyze uridine 5'-diphosphate ( UDP ) -glucuronosyltransferases ( UGTs ) ; isoform UGT1A4 probably major route metabolism human ( 3 ) . The pathway inhibited valproate induce anticonvulsant ( 3 ) , explain effect drug lamotrgine metabolism ( 4 ) . Other drug metabolize via direct glucoronidation may interfere metabolism lamotrigine e.g . acetaminophen ( 5 ) . Estrogeneous substrate metabolize via glucuronidation ( 6-8 ) may potentially interact metabolism lamotrigine . In development lamotrigine use epilepsy patient effect oral contraceptive pill study . In contrast commonly use antiepileptic drug e.g . carbamazepine phenytoin ( 9 ) , lamotrigine significantly influence constituent oral contraceptive pill ( 10-12 ) . In addition , initially assume population pharmacokinetic study , oral contraceptive influence metabolism lamotrigine ( 13 ) .However , recent retrospective study indicate oral contraceptive may increase metabolism lamotrigine result significant decrease plasma concentration lamotrigine give oral contraceptive ( 14 ; 15 ) . This effect probably related ethinyl estradiol content combine contracetive pill progesterone content ( 16 ) . To confirm extend finding , present study evaluate effect oral contraceptive lamotrigine plasma concentration double blind , placebo control , cross-over study patient epilepsy . Reference List 1 . French JA , Kanner AM , Bautista J , Abou-Khalil B , Browne T , Harden CL et al . Efficacy Tolerability New Antiepileptic Drugs , II : Treatment Refractory Epilepsy : Report TTA QSS Subcommittees American Academy Neurology American Epilepsy Society . Epilepsia 2004 ; 45 ( 5 ) :410-423 . 2 . French JA , Kanner AM , Bautista J , Abou-Khalil B , Browne T , Harden CL et al . Efficacy Tolerability New Antiepileptic Drugs , I : Treatment New-Onset Epilepsy : Report TTA QSS Subcommittees American Academy Neurology American Epilepsy Society . Epilepsia 2004 ; 45 ( 5 ) :401-409 . 3 . Dickins M , Chen C. Lamotrigine . Chemistry , Biotransformation Pharmacokinetics . In : Levy RH , Mattson RH , Meldrum BS , Perucca E , editor . Antiepileptic Drugs . Philidelphia : Lippincott , Williams &amp; Wilkins , 2002 : 370-379 . 4 . Patsalos PN , Perucca E. Clinically important drug interaction epilepsy : general feature interaction antiepileptic drug . Lancet Neurol 2003 ; 2 ( 6 ) :347-356 . 5 . Depot M , Powell JR , Messenheimer JAJ , Cloutier G , Dalton MJ . Kinetic effect multiple oral dos acetaminophen single oral dose lamotrigine . Clin Pharmacol Ther 1990 ; 48 ( 4 ) :346-355 . 6 . Tephly TR , Green MD . UDP-Glucuronosyltransferases . In : Levy RH , Thummel KE , Trager W , Hansten PD , Eichelbaum M , editor . Metabolic Drug Interactions . Philidelphia : Lippincott , Williams &amp; Wilkins , 2000 : 161-174 . 7 . Shipkova M , Wieland E. Glucuronidation therapeutic drug monitoring . Clin Chim Acta 2005 ; 358 ( 1-2 ) :2-23 . 8 . Ebner T , Remmel RP , Burchell B . Human bilirubin UDP-glucuronosyltransferase catalyzes glucuronidation ethinylestradiol . Mol Pharmacol 1993 ; 43 ( 4 ) :649-654 . 9 . Patsalos PN , Perucca E. Clinically important drug interaction epilepsy : interaction antiepileptic drug drug . Lancet Neurol 2003 ; 2 ( 8 ) :473-481 . 10 . Crawford P. Interactions antiepileptic drug hormonal contraception . CNS Drugs 2002 ; 16 ( 4 ) :263 -72 2002 ; 16 ( 4 ) :263-272 . 11 . Doose DR , Wang SS , Padmanabhan M , Schwabe S , Jacobs D , Bialer M. Effect topiramate carbamazepine pharmacokinetics oral contraceptive contain norethindrone ethinyl estradiol healthy obese nonobese female subject . Epilepsia 2003 Apr ; 44 ( 4 ) :540 -9 44 ( 4 ) :540-549 . 12 . Holdish T , Whiteman P , Orme M , Back D , Ward S. Effect lamotrigine pharmacology combine oral contraceptive pill . Epilepsia 32 [ suppl . 1 ] , s96 . 1991 . 13 . Hussein Z , Posner J . Population pharmacokinetics lamotrigine monotherapy patient epilepsy : retrospective analysis routine monitoring data . Br J Clin Pharmacol 1997 ; 43 ( 5 ) :457-465 . 14 . Sabers A , Ohman I , Christensen J , Tomson T. Oral contraceptives reduce lamotrigine plasma level . Neurology 2003 Aug 26 ; 61 ( 4 ) :570 -1 2003 ; 61 ( 4 ) :570-571 . 15 . Sabers A , Buchholt JM , ULDALL P , Hansen EL . Lamotrigine plasma level reduce oral contraceptive . Epilepsy Res 2001 Nov ; 47 ( 1 -2 ) :151 -4 47 ( 1-2 ) :151-154 . 16 . Reimers A , Helde G , Brodtkorb E. Ethinyl estradiol , progestogen , reduces lamotrigine serum concentration . Epilepsia 2005 ; 46 ( 9 ) :1414-1417 .</detailed_description>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Women epilepsy , treat lamotrigine monotherapy take combination type oral contraceptive , 18 40 year age , candidate inclusion study . Patients agree use contraception barrier type throughout study ( see study design ) . Patients admit study follow criterion present : ( 1 ) pregnancy , ( 2 ) breastfeeding , ( 3 ) affect liver function , ( 4 ) affect kidney function , ( 5 ) daily intake drug know suspected influence metabolism lamotrigine ( acetaminophen sertralin ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Lamotrigine</keyword>
	<keyword>Oral Contraceptives</keyword>
	<keyword>UGT</keyword>
	<keyword>Glucuronidation .</keyword>
</DOC>